1. Home
  2. GKOS vs ATI Comparison

GKOS vs ATI Comparison

Compare GKOS & ATI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • ATI
  • Stock Information
  • Founded
  • GKOS 1998
  • ATI 1960
  • Country
  • GKOS United States
  • ATI United States
  • Employees
  • GKOS N/A
  • ATI N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • ATI Steel/Iron Ore
  • Sector
  • GKOS Health Care
  • ATI Industrials
  • Exchange
  • GKOS Nasdaq
  • ATI Nasdaq
  • Market Cap
  • GKOS 7.4B
  • ATI 8.0B
  • IPO Year
  • GKOS 2015
  • ATI N/A
  • Fundamental
  • Price
  • GKOS $145.90
  • ATI $55.97
  • Analyst Decision
  • GKOS Strong Buy
  • ATI Buy
  • Analyst Count
  • GKOS 13
  • ATI 8
  • Target Price
  • GKOS $143.00
  • ATI $74.83
  • AVG Volume (30 Days)
  • GKOS 496.0K
  • ATI 1.1M
  • Earning Date
  • GKOS 11-04-2024
  • ATI 01-30-2025
  • Dividend Yield
  • GKOS N/A
  • ATI N/A
  • EPS Growth
  • GKOS N/A
  • ATI N/A
  • EPS
  • GKOS N/A
  • ATI 2.61
  • Revenue
  • GKOS $360,347,000.00
  • ATI $4,253,399,999.00
  • Revenue This Year
  • GKOS $22.68
  • ATI $4.25
  • Revenue Next Year
  • GKOS $24.98
  • ATI $6.67
  • P/E Ratio
  • GKOS N/A
  • ATI $21.17
  • Revenue Growth
  • GKOS 18.70
  • ATI 3.24
  • 52 Week Low
  • GKOS $74.75
  • ATI $38.04
  • 52 Week High
  • GKOS $147.65
  • ATI $68.92
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 58.40
  • ATI 40.18
  • Support Level
  • GKOS $137.60
  • ATI $55.02
  • Resistance Level
  • GKOS $147.50
  • ATI $57.20
  • Average True Range (ATR)
  • GKOS 4.74
  • ATI 1.46
  • MACD
  • GKOS 0.45
  • ATI -0.26
  • Stochastic Oscillator
  • GKOS 87.80
  • ATI 16.18

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About ATI ATI Inc.

ATI Inc supplies specialty metals to various end markets, including aerospace and defense, oil and gas, automotive, and electrical energy, among many others. The company's operating segment includes High-Performance Materials and Components and Advanced Alloys and Solutions. The majority of revenue is from the High-Performance Materials segment. The High-Performance Materials segment is focused on a wide range of high-performance specialty materials, parts, and components for several major end markets, including the aerospace & defense, medical, and energy markets. Geographically, it operates in the United States, China, the United Kingdom, Germany, France, Canada, and Others, the majority is from the United States.

Share on Social Networks: